API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Platinum dioxide:Application and Chemical Studies

Platinum dioxide as a noble metal oxide catalyst, has a wide range of applications in hydrogenation, hydrogenolysis, dehydrogenation and oxidation reactions.

Feb 14,2023  API

(2-Bromoethyl)benzene:Application and Preparation

(2-Bromoethyl)benzene is an inhibitor of histone demethylase, an amine compound having anticancer activity and a therapeutic agent for eye disorders.

Feb 14,2023  API

Preparation and Application of the Guanidine Carbonate

Guanidine carbonate, also known as carbonic acid aminourea. It can be dissolved in water and slightly dissolved in ethanol and acetone.

Feb 14,2023  API

Methanesulfonic anhydride:Application and Chemical Studies

Methanesulfonic anhydride with the form of the white solid as an anhydride of methanesulfonic acid , has been used as an excellent reagent for the improvement in Friedel-Crafts acylation reaction.

Feb 13,2023  API

Lactonic Sophorolipid:Mechanisms, Application, Chemical And Toxicity Studies

Lactonic sophorolipid is a glycolipid molecule synthesized from specific yeast species.

Feb 13,2023  API

Lactoferrin:Activity and application studies

Lactoferrin, a prominent protein in milk, many other secretory fluids and white blood cells, is a monomeric, 80-kDa glycoprotein, with a single polypeptide chain of about 690 amino acid residues.

Feb 10,2023  API

The introduction of GLOBULINS, CAT GAMMA

The GLOBULINS, CAT GAMMA, with the CAS No: 9007-83-4, is also known as MOUSE GAMMA GLOBULIN, or MOUSE GAMMA-GLOBULIN, SERUM. GLOBULINS, CAT GAMMA is a kind of protein in the blood.

Feb 3,2023  API

The introduction of Unii-fys6T7F842

The Unii-fys6T7F842, with the CAS No: 331731-18-1, is the first human anti-tumor necrosis factor approved for marketing in the world.

Feb 3,2023  API

The introduction of Methanesulfonato{[4-(N,N-Dimethylamino)Phenyl]Di-T-Butylphosphino}(2'-Amino-1,1'-Biphenyl-2-Yl)Palladium(II)

The Methanesulfonato{[4-(N,N-Dimethylamino)Phenyl]Di-T-Butylphosphino}(2'-Amino-1,1'-Biphenyl-2-Yl)Palladium(II), with the CAS No: 1820817-64-8, is also known as Amphos Palladacycle Gen. 3.

Feb 3,2023  API

An Introduction to Melphalan and Its Mechanism of Carcinogenesis

Melphalan is an alkylating antineoplastic agent used for high-dose conditioning prior to hematopoietic stem cell transplant in patients with multiple myeloma.

Feb 3,2023  API
Prev12345678910...Next>  Go to Page